Visaman Global Sales Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Visaman Global Sales Ltd is ₹ 19.5 as of 30 Oct 15:30 . The P/E Ratio of Visaman Global Sales Ltd is 23.2 as of March 2025 .The P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd is 0 as of March 2025 . The Market Cap of Visaman Global Sales Ltd is ₹ 49.72 crore as of March 2025 .The Market Cap of Welcure Drugs & Pharmaceuticals Ltd is ₹ 0 crore as of March 2025 . The revenue of Visaman Global Sales Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 1.46 crore. This represent the decline of -100% The ebitda of Visaman Global Sales Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ -49.86 crore as compare to the Dec '25 ebitda of ₹ 1.43 crore. This represent the decline of -3586% The net profit of Visaman Global Sales Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ -0.34 crore to ₹ -49.86 crore over 8 quarters. This represents a CAGR of 1110.98% The Dividend Payout of Visaman Global Sales Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Visaman Global Sales Ltd

Visaman Global Sales Limited was originally incorporated on June 27, 2019 with the Registrar of Companies, Central Registration Centre.
The Company is engaged in the business of supply of round pipes, square pipes, rectangle pipes, various specification of structural steels, BGL coils, GP(GI) coils, HR coils, CR coils, colour coated coils, MS sheets, GP and GC sheets, CR sheets, HR sheets and plates, colour coated sheets, roofing PUF panel, wall PUF panel etc.
Further, it also provide the credit facility to the existing customers as value added service.
It outsource the process of modification and alteration to the third party.
Additionally, it facilitate onsite delivery of products to the customers.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Visaman Global Sales Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Visaman Global Sales Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Visaman Global Sales Ltd is 39 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Visaman Global Sales Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Visaman Global Sales Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Visaman Global Sales Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 31, 2026, the Visaman Global Sales Ltd stock price is INR ₹19.5. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Visaman Global Sales Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Visaman Global Sales Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.